ArticleFrontiers in immunology2021
A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
Xiaohan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
67 papers cite itlatest 60 shown
this papercites it
ArticleFrontiers in immunology2021
Xiaohan Zhou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.